CLU and Alzheimer disease: Furthermore, since clusterin is already present in CSF at a concentration of about 90 nM both for individuals affected with AD and for HC (Vranová et al., 2014), this result suggests that in CSF such concentrations are not high enough to be totally effective at reducing Ca2+ influx.